HRT FINANCIAL LP - STRONGBRIDGE BIOPHARMA PLC ownership

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2021$196,000
-46.7%
96,533
-22.2%
0.00%
-66.7%
Q2 2021$368,000
+951.4%
124,115
+639.3%
0.00%
+50.0%
Q4 2019$35,000
-44.4%
16,788
-17.8%
0.00%
-50.0%
Q2 2019$63,00020,4220.00%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q4 2021
NameSharesValueWeighting ↓
CAXTON CORP 6,612,065$12,497,00013.66%
Ikarian Capital, LLC 3,392,787$6,412,0000.48%
NEA Management Company, LLC 4,141,308$7,827,0000.41%
Alambic Investment Management, L.P. 61,764$117,0000.28%
KNOTT DAVID M 181,800$344,0000.22%
683 Capital Management, LLC 917,942$1,736,0000.10%
Hudson Bay Capital Management LP 1,409,419$2,664,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 388,309$734,0000.06%
&PARTNERS 15,000$28,0000.04%
Diversified Trust Co 198,534$375,0000.02%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders